Avaleht › Südamepuudulikkus › Arizona › Phoenix
Südamepuudulikkus kliinilised uuringud linnas Phoenix, AZ
18 uuringut haiguse Südamepuudulikkus jaoks otsivad osalejaid linnas Phoenix ja selle ümbruses (umbes 30 miili raadiuses). Avage uuring, et näha, kes saab osaleda ja kuidas võtta ühendust uuringumeeskonnaga.
Ametlik uuringutekst (inglise keeles)
Otsite osalejaid uuringusse? Esitlege seda selle lehe tipus – $99 30 päeva eest →
ELEVATE-HFpEF Clinical Study
Värbamine
- Banner - University Medical Center Phoenix, Phoenix
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Heart Failure and Impaired Kidney Function
VärbamineFaas 3
- Research Site, Phoenix
- Research Site, Phoenix
BiVACOR® Total Artificial Heart Early Feasibility Study
Värbamine
- Banner - University Medical Center Phoenix, Phoenix
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
VärbamineFaas 3
- HonorHealth, Phoenix
- Medical Advancement Centers of Arizona, Phoenix
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)
VärbamineFaas 3
- Phoenix, AZ Investigative Site CON-10115, Phoenix
A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients
VärbamineFaas 3
- Phoenix, AZ Investigative Site 10115, Phoenix
Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure
Värbamine
- Mayo Clinic Phoenix, Phoenix
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
Värbamine
- Banner--University Medical Center Phoenix, Phoenix
- Mayo Clinic - Arizona, Phoenix
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
VärbamineFaas 3
- Honor Health, Phoenix
- Arizona Research Center, Phoenix
Assessment of CCM in HF With Higher Ejection Fraction
Värbamine
- Arizona Heart Rhythm, Phoenix
- Cardiovascular Consultants, Ltd, Phoenix
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists
VärbamineFaas 3
- Phoenix, AZ Investigative Site FIN-10115, Phoenix
PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III
Värbamine
- St. Joseph's Hospital and Medical Center, Phoenix
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
Värbamine
- Banner-University Medical Center Phoenix, Phoenix
CCM OPEN HF Registry
VärbamineVaatlusuuring
- University of Arizona and Banner University Medical Center Phoenix, Phoenix
- HonorHealth Research Institute, Phoenix
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Värbamine
- Banner Health - Phoenix, Phoenix
Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment
Värbamine
- Arizona Heart Foundation, Phoenix
His-Bundle Corrective Pacing in Heart Failure
Värbamine
- University of Arizona, Phoenix
Care Coordination to Assess Improvement in Outcomes in Hospital Readmissions
VärbamineTerved vabatahtlikud oodatud
- Multiple Locations, Phoenix
Südamepuudulikkus uuringud teistes linnades
- New York City, NY51 uuringut
- Boston, MA44 uuringut
- Dallas, TX42 uuringut
- Houston, TX36 uuringut
- Cleveland, OH33 uuringut
- Chicago, IL31 uuringut
- Philadelphia, PA31 uuringut
- San Francisco, CA29 uuringut
- St. Louis, MO26 uuringut
- Durham, NC26 uuringut
- Kansas City, MO25 uuringut
- Atlanta, GA25 uuringut
Muud uuringud linnas Phoenix
- Rinnavähk25 uuringut
- Käär- ja pärasoolevähk25 uuringut
- Rasvumine22 uuringut
- Mitteväikerakuline kopsuvähk20 uuringut
- Metastaatiline vähk20 uuringut
- Eesnäärmevähk17 uuringut
- Vähk (kõik liigid)17 uuringut
- Müeloom16 uuringut
- Pankreasevähk16 uuringut
- Kardiovaskulaarsed haigused16 uuringut
- Alzheimeri tõbi15 uuringut
- Ülekaalulisus15 uuringut
Allikas ClinicalTrials.gov, andmed saadud 5. okt 2026. Igal uuringul on oma osalemiskõlblikkuse tingimused; uuringumeeskond otsustab, kes saab osaleda.